Literature DB >> 10735506

Correlation of metallothionein expression with apoptosis in nasopharyngeal carcinoma.

A Jayasurya1, B H Bay, W M Yap, N G Tan.   

Abstract

The expression of metallothionein (MT), an intracellular ubiquitous low molecular weight protein thiol with antioxidant properties, was studied in nasopharyngeal cancer (NPC) and correlated with the apoptotic index. Immunohistochemical staining of randomly selected, formalin-fixed and paraffin-embedded normal and malignant nasopharyngeal tissues were analysed for the expression of MT using the commercially available E9 antibody directed against MT I and MT II isoforms. The corresponding apoptosis labelling indices were evaluated by the TUNEL method. Localization of MT at the ultrastructural level was studied by immunogold labelling. All the tumour sections (17 specimens) showed MT-immunopositivity. A direct correlation between the percentage of MT-positive cells and the staining intensity was noted (P < 0.001; Pearson's r = 0.95). There was absence of cytoplasmic staining and only nuclear staining (with localization in the nucleoplasm) was demonstrated in the tumour cells. In normal epithelium of the nasopharynx, the basal layer was stained. An inverse relationship was observed between the level of MT expression and the apoptotic index in the NPC tissues (P = 0.0059; Pearson's r = -0.6380). The results suggest that overexpression of MT in NPC may protect the tumour cells from entering into the apoptotic process and thereby contribute to tumour expansion. Preferential localization of MT in the nuclei of NPC cells may possibly enhance radioresistance since radiotherapy is known to eradicate tumour cells by free radical-induced apoptosis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10735506      PMCID: PMC2363356          DOI: 10.1054/bjoc.1999.1063

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  28 in total

1.  Quantification and identification of metallothioneins by gel electrophoresis and silver staining.

Authors:  C C McCormick; L Y Lin
Journal:  Methods Enzymol       Date:  1991       Impact factor: 1.600

2.  Metallothionein expression and nuclear size in benign, borderline, and malignant serous ovarian tumours.

Authors:  Y Tan; R Sinniah; B H Bay; G Singh
Journal:  J Pathol       Date:  1999-09       Impact factor: 7.996

3.  Immunohistochemical localization of metallothionein in human testicular embryonal carcinoma cells.

Authors:  T E Kontozoglou; D Banerjee; M G Cherian
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989

4.  Histopathology of nasopharyngeal carcinoma: correlations with epidemiology, survival rates and other biological characteristics.

Authors:  K Shanmugaratnam; S H Chan; G de-Thé; J E Goh; T H Khor; M J Simons; C Y Tye
Journal:  Cancer       Date:  1979-09       Impact factor: 6.860

Review 5.  Programmed cell death and radioresistance.

Authors:  R E Meyn; L C Stephens; L Milas
Journal:  Cancer Metastasis Rev       Date:  1996-03       Impact factor: 9.264

6.  Markers of chemoresistance in ovarian carcinomas: an immunohistochemical study of 86 cases.

Authors:  I Germain; B Têtu; J Brisson; M Mondor; M G Cherian
Journal:  Int J Gynecol Pathol       Date:  1996-01       Impact factor: 2.762

7.  Immunohistochemically demonstrated metallothionein expression in malignant melanoma.

Authors:  B Zelger; A Hittmair; M Schir; C Ofner; D Ofner; P O Fritsch; W Böcker; B Jasani; K W Schmid
Journal:  Histopathology       Date:  1993-09       Impact factor: 5.087

8.  Nasopharyngeal carcinoma: treatment results with primary radiation therapy.

Authors:  J W Bailet; R J Mark; E Abemayor; S P Lee; L M Tran; G Juillard; P H Ward
Journal:  Laryngoscope       Date:  1992-09       Impact factor: 3.325

9.  p53 mutation in human nasopharyngeal carcinomas.

Authors:  K W Lo; C H Mok; D P Huang; Y X Liu; P H Choi; J C Lee; S W Tsao
Journal:  Anticancer Res       Date:  1992 Nov-Dec       Impact factor: 2.480

10.  Subcellular localization of metallothionein IIA in human bladder tumor cells using a novel epitope-specific antiserum.

Authors:  S M Kuo; Y Kondo; J M DeFilippo; M S Ernstoff; R R Bahnson; J S Lazo
Journal:  Toxicol Appl Pharmacol       Date:  1994-03       Impact factor: 4.219

View more
  11 in total

1.  Identification of heat shock protein 27 as a radioresistance-related protein in nasopharyngeal carcinoma cells.

Authors:  Bin Zhang; Jia-Quan Qu; Liang Xiao; Hong Yi; Peng-Fei Zhang; Mao-Yu Li; Rong Hu; Xun-Xun Wan; Qiu-Yan He; Jian-Huang Li; Xu Ye; Zhi-Qiang Xiao; Xue-Ping Feng
Journal:  J Cancer Res Clin Oncol       Date:  2012-07-31       Impact factor: 4.553

Review 2.  Metallothionein: an overview.

Authors:  N Thirumoorthy; K-T Manisenthil Kumar; A Shyam Sundar; L Panayappan; Malay Chatterjee
Journal:  World J Gastroenterol       Date:  2007-02-21       Impact factor: 5.742

3.  Using yeast two-hybrid system to identify ECRG2 associated proteins and their possible interactions with ECRG2 gene.

Authors:  Yong-Ping Cui; Jian-Bo Wang; Xin-Yu Zhang; Mei-Xia Bi; Li-Ping Guo; Shih-Hsin Lu
Journal:  World J Gastroenterol       Date:  2003-09       Impact factor: 5.742

4.  Metallothionein expression in hepatocellular carcinoma.

Authors:  Geng-Wen Huang; Lian-Yue Yang
Journal:  World J Gastroenterol       Date:  2002-08       Impact factor: 5.742

5.  Differential expression of metallothionein 1 and 2 isoforms in breast cancer lines with different invasive potential: identification of a novel nonsilent metallothionein-1H mutant variant.

Authors:  Siew-Kian Tai; Owen June-Keong Tan; Vincent Tak-Kwong Chow; Rongxian Jin; J Louise Jones; Puay-Hoon Tan; Anita Jayasurya; Boon-Huat Bay
Journal:  Am J Pathol       Date:  2003-11       Impact factor: 4.307

Review 6.  Clinicopathological significance of metallothioneins in breast cancer.

Authors:  Rongxian Jin; Jingxiang Huang; Puay-Hoon Tan; Boon-Huat Bay
Journal:  Pathol Oncol Res       Date:  2004-06-09       Impact factor: 2.874

7.  The Potential Role of MT and Vimentin Immunoreactivity in the Remodeling of the Microenvironment of Parotid Adenocarcinoma.

Authors:  Magdalena Dutsch-Wicherek; Agata Lazar; Romana Tomaszewska
Journal:  Cancer Microenviron       Date:  2010-12-15

8.  Metallothionein 1E mRNA is highly expressed in oestrogen receptor-negative human invasive ductal breast cancer.

Authors:  R Jin; B H Bay; V T Chow; P H Tan; V C Lin
Journal:  Br J Cancer       Date:  2000-08       Impact factor: 7.640

Review 9.  Metallothionein as an anti-inflammatory mediator.

Authors:  Ken-ichiro Inoue; Hirohisa Takano; Akinori Shimada; Masahiko Satoh
Journal:  Mediators Inflamm       Date:  2009-05-11       Impact factor: 4.711

10.  Analysis of metallothionein and vimentin immunoreactivity in pharyngeal squamous cell carcinoma and its microenvironment.

Authors:  Magdalena Dutsch-Wicherek; Agata Lazar; Romana Tomaszewska; Wojciech Kazmierczak; Lukasz Wicherek
Journal:  Cell Tissue Res       Date:  2013-02-09       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.